Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: C-reactive protein (CRP) is associated with the risk of cardiovascular disease (CVD); whether the effects are modified by diabetes status still is unclear. This study investigated these issues and assessed the added value of CRP to predictions. RESEARCH DESIGN AND METHODS: Participants were drawn from representative samples of adults living in England and Scotland. Cox proportional hazards regression models were used to relate baseline plasma CRP with all-cause and CVD mortality during follow-up in men and women with and without diabetes. The added value of CRP to the predictions was assessed through c-statistic comparison and relative integrated discrimination improvement. RESULTS: A total of 25,979 participants (4.9% with diabetes) were followed for a median of 93 months, during which period there were 2,767 deaths (957 from CVD). CRP (per SD loge) was associated with a 53% (95% CI 43–64) and 43% (38–49) higher risk of cardiovascular and all-cause mortality, respectively. These associations were log linear and did not differ according to diabetes status (both P ≥ 0.08 for interaction), sex, and other risk factors. Adding CRP to conventional risk factors improved predictions overall and separately by diabetes status but not for CVD mortality, although such improvements only were marginal based on several discrimination statistics. CONCLUSIONS: The association between CRP and CVD was similar across diabetes status, and the effects are broadly similar across levels of other conventional risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“elevated hsCRP has been found to be predictive of major adverse CV events and death in individuals with or without type 2 diabetes and/or previous CV events [35].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674 · cited 1×
“The JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) has shown that CRPwas useful for targeting statin therapy in healthy individuals with normal-range LDL cholesterol (32).”
MethodPencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 2×
“The relative integrated discrimination improvement (RIDI%), which measures the percentage improvement in discrimination when an extra variable is added to a prediction model (16), was computed.”
MethodRosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · cited 2×
“In addition, it has been demonstrated that CRP was stable enough for use in long-term predictions (3).”
Background(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546 · cited 7×
“In theEmerging Risk Factors Collaboration (ERFC) overview,where statistical interactionwas tested, CRP was a similar determinant of coronary heart disease in participants with diabetes and those without (7).”
BackgroundMethodResultInfluentialCardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163 · cited 1×
“The incremental value of CRP was further assessed by refitting the Framingham Anderson general equation for the prediction of cardiovascular mortality (without electrocardiographic left ventricular hypertrophy, a missing predictor in our sample) data with and without CRP (19).”
MethodModelling for Survival Data in Medical Research
(1995) · Technometrics · doi:10.1080/00401706.1995.10485920 · Cited by 2,145
Checking the Cox model with cumulative sums of martingale-based residuals
LIN, D. Y., WEI, L. J., & YING, Z. (1993) · Biometrika · doi:10.1093/biomet/80.3.557 · Cited by 1,432 · cited 1×
“The proportional hazards assumption was tested with the use of the cumulative sums of Martingale-based residuals methods (12) and found not to be violated.”
MethodGreenland, P. (2008) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Cited by
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.006 · Cited by 1,981
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
“The identification of potential pathways connecting inflammation to diabetes has produced growing interest in targeting inflammation to help prevent and control diabetes and related conditions, as well as improving risk stratification for diabetes by using inflammatory biomarkers as potential indexes.(23,24)”
BackgroundDiabetes Mellitus and Inflammation
Lontchi-Yimagou, E., Sobngwi, E., Matsha, T. E., & Kengne, A. P. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0375-y · Cited by 807
Self-citationCardiovascular risk assessment in patients with diabetes
Bertoluci, M. C., & Rocha, V. Z. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0225-1 · Cited by 255
Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Grossmann, V., Schmitt, V. H., Zeller, T., Panova-Noeva, M., Schulz, A., Laubert-Reh, D., Juenger, C., Schnabel, R. B., Abt, T. G. J., Laskowski, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3008 · Cited by 257
Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01409-0 · Cited by 198
“In two previous large population-based cohort studies, higher levels of hs-CRP were also related to higher risk of cardiovascular mortality, in line with our current findings [28, 29].”
ResultEffect of resistance training on inflammatory markers of older adults: A meta-analysis
Sardeli, A. V., Tomeleri, C. M., Cyrino, E. S., Fernhall, B., Cavaglieri, C. R., & Chacon-Mikahil, M. P. T. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.021 · Cited by 168
Zuo, H., Ueland, P. M., Ulvik, A., Eussen, S. J. P. M., Vollset, S. E., Nygård, O., Midttun, Ø., Theofylaktopoulou, D., Meyer, K., & Tell, G. S. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv242 · Cited by 167
Cohort profile: the German Diabetes Study (GDS)
The GDS Group, Szendroedi, J., Saxena, A., Weber, K. S., Strassburger, K., Herder, C., Burkart, V., Nowotny, B., Icks, A., Kuss, O., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0374-9 · Cited by 151
“Both DM and its comorbidities have in common that inflammation-related processes are involved in their development [47–49].”
BackgroundBouchi, R., Nakano, Y., Fukuda, T., Takeuchi, T., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0449 · Cited by 113
Mavros, Y., Kay, S., Simpson, K. A., Baker, M. K., Wang, Y., Zhao, R. R., Meiklejohn, J., Climstein, M., O'Sullivan, A. J., de Vos, N., et al. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0134-1 · Cited by 91
Hsieh, P.-L., Tseng, C.-H., Tseng, Y. J., & Yang, W.-S. (2018) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000107 · Cited by 87
Mosenzon, O., Capehorn, M. S., De Remigis, A., Rasmussen, S., Weimers, P., & Rosenstock, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01585-7 · Cited by 91
C-Reactive Protein As a Marker of Melanoma Progression
Fang, S., Wang, Y., Sui, D., Liu, H., Ross, M. I., Gershenwald, J. E., Cormier, J. N., Royal, R. E., Lucci, A., Schacherer, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0209 · Cited by 85
“An elevated level of CRP is a risk factor for cardiovascular disease and death resulting from cardiovascular causes in both men and women.(7-14) Prior investigations have demonstrated an association between CRP level and colorectal or lung cancer, but prospective studies have provided inconsistent evidence for an etio…”
BackgroundAl-Salameh, A., Chanson, P., Bucher, S., Ringa, V., & Becquemont, L. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.007 · Cited by 77
Ribeiro, A. S., Tomeleri, C. M., de Souza, M. F., Pina, F. L. C., Schoenfeld, B. J., do Nascimento, M. A., Venturini, D., Barbosa, D. S., & Cyrino, E. S. (2015) · AGE · doi:10.1007/s11357-015-9849-y · Cited by 95
Mazidi, M., Kengne, A. P., Mikhailidis, D. P., Cicero, A. F., & Banach, M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1325967 · Cited by 73
Self-citationSchöttker, B., Herder, C., Rothenbacher, D., Roden, M., Kolb, H., Müller, H., & Brenner, H. (2013) · Diabetes Care · doi:10.2337/dc12-1416 · Cited by 63
COVID-19 and Diabetes Mellitus: The Link and Clinical Implications
Ugwueze, C. V., Ezeokpo, B. C., Nnolim, B. I., Agim, E. A., Anikpo, N. C., & Onyekachi, K. E. (2020) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000511354 · Cited by 66
Gracia‐Marco, L., Moreno, L. A., Ruiz, J. R., Ortega, F. B., de Moraes, A. C. F., Gottrand, F., Roccaldo, R., Marcos, A., Gómez‐Martínez, S., Dallongeville, J., et al. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.11.002 · Cited by 68
Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes
Bachmann, K. N., & Wang, T. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4442-9 · Cited by 61
“In contrast, the predictive abilities of C-reactive protein [46], fibrinogen [47] or γ-glutamyltransferase [48] do not appear to differ by diabetes status.”
ResultAnaemia, Haemoglobin Level and Cause-Specific Mortality in People with and without Diabetes
Kengne, A. P., Czernichow, S., Hamer, M., Batty, G. D., & Stamatakis, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041875 · Cited by 59
Self-citationRibeiro, A. S., Schoenfeld, B. J., de Souza, M. F., Tomeleri, C. M., Venturini, D., Barbosa, D. S., & Cyrino, E. S. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.007 · Cited by 67
“, 2003), which is the most widely used biomarker of systemic inflammation and considered an independent factor of cardiovascular disease (Kengne et al., 2012; Selvin et al., 2007).”
BackgroundTian, R., Tian, M., Wang, L., Qian, H., Zhang, S., Pang, H., Liu, Z., Fang, L., & Shen, Z. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.005 · Cited by 63
Ni, P., Yu, M., Zhang, R., Cheng, C., He, M., Wang, H., Chen, S., & Duan, G. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.07.005 · Cited by 56
The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy
Sanganalmath, S. K., Dubey, S., Veeranki, S., Narisetty, K. K., & Krishnamurthy, P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01755-1 · Cited by 58
Tang, O., Daya, N. R., Matsushita, K., Coresh, J., Sharrett, A. R., Hoogeveen, R. C., Jia, X., Windham, B. G., Ballantyne, C. M., & Selvin, E. (2020) · Diabetes Care · doi:10.2337/dc19-2043 · Cited by 49
Lin, K., Lan, Y., Ai, W., Yan, Y., & Ge, J. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.03.013 · Cited by 54
Hung, M., Hsu, K., Hu, W., Chang, N., & Hung, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077655 · Cited by 46
The regulatory role of insulin in energy metabolism and leukocyte functions
Cruz-Pineda, W. D., Parra‐Rojas, I., Rodríguez-Ruiz, H. A., Illades‐Aguiar, B., Matia‐García, I., & Garibay‐Cerdenares, O. L. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ru1220-847r · Cited by 55
Is the Risk and Nature of CVD the Same in Type 1 and Type 2 Diabetes?
Duca, L. M., Sippl, R., & Snell‐Bergeon, J. K. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0380-1 · Cited by 50
“In 2012, a much larger study of over 25,000 adults in England and Scotland demonstrated that each standard deviation increase in CRP was associated with a 53 % increase in CVD mortality and a 43 % increase in overall mortality in adults both with and without diabetes [81].”
BackgroundHwang, Y., Morrow, D. A., Cannon, C. P., Liu, Y., Bergenstal, R. M., Heller, S. R., Mehta, C. R., Cushman, W. C., Bakris, G. L., Zannad, F. M., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13136 · Cited by 45
Løfblad, L., Hov, G. G., Åsberg, A., & Videm, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-94995-8 · Cited by 46
Cardoso, C. R. L., Leite, N. C., & Salles, G. F. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004554 · Cited by 36
Cunha, P. M., Ribeiro, A. S., Nunes, J. P., Tomeleri, C. M., do Nascimento, M. A., Moraes, G. K., Sugihara, P., Barbosa, D. S., Venturini, D., & Cyrino, E. S. (2018) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2018.12.012 · Cited by 43
Hoseinpour, A. N., Bassami, M., Ahmadizad, S., Donath, L., Setayesh, S., Mirzaei, M., & Rahimi, G. R. M. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105731 · Cited by 40
on behalf of the CARDS Investigators, Soedamah‐Muthu, S. S., Livingstone, S. J., Charlton-Menys, V., Betteridge, D. J., Hitman, G. A., Neil, H. A. W., Bao, W., DeMicco, D. A., Preston, G. M., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3586-8 · Cited by 39
Cunha, P. M., Tomeleri, C. M., do Nascimento, M. A., Mayhew, J. L., Fungari, E., Cyrino, L. T., Barbosa, D. S., Venturini, D., & Cyrino, E. S. (2019) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003245 · Cited by 43
“In addition, more recent evidence has shown that RT can be an effective strategy for reducing body fat (9,40), enhancing lipid profile (7,15), and reducing concentrations of CRP (33,40), all of which are important independent indicators of mortality for cardiovascular and metabolic diseases (16,17).”
BackgroundBhati, P., Alam, R., Moiz, J. A., & Hussain, M. E. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00435-w · Cited by 39
Kengne, A. P. (2013) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2013-078 · Cited by 39
Self-citationDrinking Orange Juice Increases Total Antioxidant Status and Decreases Lipid Peroxidation in Adults
Foroudi, S., Potter, A. S., Stamatikos, A., Patil, B. S., & Deyhim, F. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.0034 · Cited by 32
Klimontov, V. V., Тян, Н. В., Fazullina, O. N., Myakina, N. E., Lykov, A. P., & Konenkov, V. I. (2016) · Diabetes Mellitus · doi:10.14341/dm7928 · Cited by 31
Asbaghi, O., Ashtary‐Larky, D., Mousa, A., Kelishadi, M. R., & Moosavian, S. P. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab121 · Cited by 31
Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes
Kamalumpundi, V., Shams, E., Tucker, C., Cheng, L., Peterson, J., Thangavel, S., Ofori, O., & Correia, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115304 · Cited by 38
Sex and Race Differences in the Relationship between Obesity and C-Reactive Protein
Clark, D. O., Unroe, K. T., Xu, H., Keith, N. R., Callahan, C. M., & Tu, W. (2016) · Ethnicity & Disease · doi:10.18865/ed.26.2.197 · Cited by 31
On the importance of global cardiovascular risk assessment in people with type 2 diabetes
Echouffo-Tcheugui, J. B., & Kengne, A. P. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.03.002 · Cited by 25
Self-citationAssociation Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout
Wang, L., Sawhney, M. S., Zhao, Y., Carpio, G., Fonseca, V. A., & Shi, L. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.03.010 · Cited by 24
“At the same time, cardiovascular diseases have been long linked to diabetes.(21,22) Prospective studies document an increased likelihood of sudden cardiac death and myocardial infarctions in patients with diabetes.”
BackgroundIncreased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes
Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107413 · Cited by 26
Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., Ishii, H., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0865 · Cited by 26
Saadati, S., Naseri, K., Asbaghi, O., Abhari, K., Zhang, P., Li, H., & Gan, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.977756 · Cited by 22
Huang, N. H., Tang, C., Li, S., Ma, W., Zhai, X., Liu, K., Sheerah, H. A., & Cao, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.976817 · Cited by 24
“However, few studies suggested that the magnitude of association between CRP and CVD mortality is comparable in people with and without diabetes (39, 41).”
BackgroundUrinary tract infections: a review of the current diagnostics landscape
Grey, B., Upton, M., & Joshi, L. T. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001780 · Cited by 24
Price, A. H., Weir, C. J., Welsh, P. I., McLachlan, S., Strachan, M. W. J., Sattar, N. A., & Price, J. F. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.07.009 · Cited by 21
Svensson, E., Mor, A., Rungby, J., Berencsi, K., Nielsen, J. S., Stidsen, J. V., Friborg, S. G., Brandslund, I., Christiansen, J. S., Beck‐Nielsen, H., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-74 · Cited by 21
Chauvet‐Gélinier, J., Trojak, B., Lemogne, C., Aho, S., Brindisi, M., Bouillet, B., Ponavoy, E., Meille, V., Simoneau, I., Chahraoui, K., et al. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.08.001 · Cited by 19
the directors of the JCS, J., Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00471-5 · Cited by 17
“An increase in hsCRP is associated with increased risk of a cardiovascular event and death [24].”
BackgroundMojtahedi, S., Moghadam, B. H., Rosenkranz, S. K., شوریده, ز., Amirshaghaghi, F., & Shabkhiz, F. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111756 · Cited by 19
Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered?
Meeusen, J. W., Donato, L. J., & Jaffe, A. S. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000313 · Cited by 16
Parrinello, C. M., Matsushita, K., Woodward, M., Wagenknecht, L. E., Coresh, J., & Selvin, E. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12686 · Cited by 18
Tomeleri, C. M., Cunha, P. M., Dib, M. M., Bortoloti, D. S., Kassiano, W., Costa, B. D. D. V., Teixeira, D. D. C., Deminice, R., Rodrigues, R. J., Venturini, D., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021165 · Cited by 20
“As a consequence of reducing inflammatory biomarkers, such as C-reactive protein, the chance of lowering possible cardiovascular complications increases [2].”
BackgroundNovel Biomarkers for Predicting Cardiovascular Disease in Patients With Diabetes
Retnakaran, R. R. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.10.017 · Cited by 15
Zhao, L., Li, Y., Lv, Q., Wang, M., Luan, Y., Song, J., Fu, G., Ge, J., Zou, Y., & Zhang, W. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1596357 · Cited by 19
“Low-level cellular inflammatory events [4, 5], such as increased tumor necrosis factor- (TNF-) α [6], C-reactive protein (CRP) [7], and interleukin- (IL-) 6 [6], have been reported to be associated with diabetes and considered to be mainly attributed to the onset of vascular complications.”
BackgroundInfluentialGlycA for long-term outcome in T2DM secondary prevention
Zierfuss, B., Höbaus, C., Herz, C. T., Pesau, G., Mrak, D., Koppensteiner, R., & Schernthaner, G.-H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108583 · Cited by 16
AKINBOBOYE, O. J., Williams, J. S., Garacci, E., & Egede, L. E. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.022 · Cited by 13
Dyslipidaemia in adults with type 1 diabetes—when to treat?
Lan, N. S. R., Fegan, P. G., Yeap, B. B., Bell, D. A., & Watts, G. F. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3090 · Cited by 14
“Studies in people with diabetes have confirmed the relationship between elevated hs‐CRP and CVD; however; risk prediction using hs‐CRP was only marginally improved.(12) In addition, lipoprotein‐associated phospholipase is an enzyme that hydrolyzes oxidized phospholipids and is a marker of atherogenic vascular inflamma…”
BackgroundZhou, H., Zhao, D., Wang, G., Wang, T., Liang, H., & Zhang, J. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01704-w · Cited by 12
Mandlik, R. V., Naik, S. R., Zine, S., Ved, H., & Doshi, G. (2022) · Planta Medica International Open · doi:10.1055/a-1712-8178 · Cited by 11
Vu, T. T., Liu, K., Lloyd‐Jones, D. M., Stamler, J., Pirzada, A., Shah, S. J., Garside, D. B., & Daviglus, M. L. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.03.012 · Cited by 10
“…for systemic inflammation, has been found to be associated with future cardiovascular disease (CVD) events and mortality (Buckley et al., 2009; Kengne et al., 2012; Libby et al., 2002; Ridker, 2003; Ridker et al., 2000; Strandberg and Tilvis, 2000) as well as with single CVD risk factors…”
BackgroundDiabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk
Piko, N., Bevc, S., Ekart, R., Petreski, T., Hojs, N. V., & Hojs, R. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.975 · Cited by 16
Efficacy of Liraglutide in clinical practice: Single centre experience
Rashid, M. O., Jabeen, S., Khoja, A. A., & Islam, N. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.3.358 · Cited by 10
Nembaware, V., Mazandu, G. K., Hotchkiss, J., Serufuri, J.-M. S., Kent, J., Kengne, A. P., Anie, K. A., Munung, N. S., Bukini, D., Bitoungui, V. J. N., et al. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0153 · Cited by 11
Self-citationAssessment of in situ adipose tissue inflammation by microdialysis
Langkilde, A., Andersen, O., Henriksen, J. H., Langberg, H., Petersen, J., & Eugen‐Olsen, J. (2014) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12134 · Cited by 10
Phulukdaree, A., Moodley, D., Khan, S., & Chuturgoon, A. A. (2013) · Gene · doi:10.1016/j.gene.2013.04.048 · Cited by 9
“Inflammation plays an integral role in initiation, progression and rupture of atherosclerotic plaques, and CRP is widely recognised as a marker for cardiovascular diseases (Hulsmans and Holvoet, 2009; Kengne et al., 2011).”
BackgroundYang, X., & Li, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1545272 · Cited by 8
Krajnc, M., Balon, B. P., & Krajnc, I. (2019) · Journal of International Medical Research · doi:10.1177/0300060518814080 · Cited by 9
Cardiometabolic Risk: Characteristics of the Intestinal Microbiome and the Role of Polyphenols
Haș, I. M., Ţiţ, D. M., BUNGAU, S. G., Pavel, F. M., Teleky, B., Vodnar, D. C., & Vesa, C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813757 · Cited by 12
“According to scientific data, chronic low-grade inflammation is correlated with the development of chronic degenerative diseases, including CVD and diabetes [124–127].”
BackgroundLee, J. H., Yeom, H., Kim, H. C., Suh, I., Kim, M. K., Shin, M., Shin, D. H., Koh, S. B., Ahn, S. V., Lee, T., et al. (2016) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.16.025 · Cited by 7
Lee, S., Kwon, S. O., Park, H., Shu, X., Lee, J., & Kang, D. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052630 · Cited by 6
Jiang, X., Chen, Q., Chen, X., Sun, Q., Jing, F., Zhang, H., Xu, J., Li, X., & Guan, Q. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03867-2 · Cited by 5
de Oliveira, D. V., Cunha, P. M., Campos, R. D. S., do Nascimento, M. A., Antunes, M. D., Júnior, J. R. A. D. N., Mayhew, J. L., & Cavaglieri, C. R. (2019) · journal of physical education · doi:10.4025/jphyseduc.v30i13053 · Cited by 5
Petelina, T. I., Musikhina, N. A., Avdeeva, K. S., Sharoyan, Y. A., Gapon, L., Gorbatenko, E. A., Зуева, Е. В., & Valeeva, L. L. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-6-325-332 · Cited by 3
Choudhry, A. A., Rajeshwari, S., Gururaja, A., Prabhu, K., & Ravishankar, N. (2014) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(14)60475-8 · Cited by 2
Zhang, Y.-W., Xu, M.-R., Li, M.-H., & Li, L. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i4.117063 · Cited by 2
Comparison of the lipids levels, C-reactive protein and adiponectin in adolescent male by fat intake
Lee, S.-H., Park, M.-Y., Kim, S.-K., & Min, Y. (2012) · Journal of Nutrition and Health · doi:10.4163/kjn.2012.45.4.303 · Cited by 1
Zhao, L., Meng, J., Bai, X., Zhang, D., Yang, X., Yu, Y., Cai, G., & Liu, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-01955-9 · Cited by 2
Screening Strategies for Type 2 Diabetes and Risk Stratification in Minorities
Kengne, A. P. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-93148-7_18 · Cited by 1
Self-citationMeasures of Endothelial Function in Type 2 Diabetes: A Focus on Circulatory Biomarkers
Hoong, C. W. S. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_68 · Cited by 1
Hackett, R. A. (2016) · UCL Discovery (University College London) · Cited by 2
Cardiovascular risk profiles in Type 2 diabetes and the impact of geographical setting
Smith‐Palmer, J., Boye, K. S., Perez‐Nieves, M., Valentine, W. J., & Bae, J. P. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.995167
Phulukdaree, A. (2012) · ResearchSpace (University of KwaZulu-Natal)
Hwang, K.-H. (2015) · Journal of the East Asian Society of Dietary Life · doi:10.17495/easdl.2015.2.25.1.111
Leung, J. Y. T. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166166
Urmanova, Y. М., Mukhtarova, S., Grossman, A. B., Mukhtarova, M., & Хусаиновна, Т. Р. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.2.2020.201293
Boczar, K. E., Liu, P. X., Chong, A., So, D. Y. F., Dowlatshahi, D. D., Rayner, K. J., & Beanlands, R. S. (2020) · CJC Open · doi:10.1016/j.cjco.2020.12.020
Urmanova, Y. М., Mukhtarova, S., Tursunkulov, O., Mukhtarova, M., & Ugli, K. F. J. (2020) · International Journal of Radiology & Radiation Therapy · doi:10.15406/ijrrt.2020.07.00278
Unwinding Link between Coronavirus and Diabetes Patient
Bhadauria, S. S., Malviya, R., & Sharma, P. K. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220329150238
Measures of Endothelial Function in Type 2 Diabetes: A Focus on Circulatory Biomarkers
Hoong, C. W. S. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_68-1
Sharif, S., van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., & Westerink, J. (2021) · Figshare · doi:10.6084/m9.figshare.16969304
Zhao, L., Meng, J., Bai, X., Zhang, D., Yang, X., Yang, Y., Cai, G., & Liu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26289566
Zhao, L., Meng, J., Bai, X., Zhang, D., Yang, X., Yang, Y., Cai, G., & Liu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26289106
Metadata
- Authors
- Kengne, A. P., Batty, G. D., Hamer, M., Stamatakis, E., & Czernichow, S.
- Affiliations
- NCRP for Cardiovascular and Metabolic Diseases, South African Medical Research Council and University of Cape Town, Cape Town, South Africa
- University College London (GB)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-01-16
- Volume
- 35
- Issue
- 2
- Pages
- 396-403
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3263864
- OpenAlex
- W2136901433
- Cited by
- 105
- References
- 40
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 8 · 2020: 13 · 2019: 8 · 2018: 4 · 2017: 6 · 2016: 12 · 2015: 10 · 2014: 7 · 2013: 7 · 2012: 3
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- C-reactive protein, cardiovascular mortality, diabetes mellitus, all-cause mortality, cardiovascular risk prediction, inflammation, sex differences
- MeSH terms
- Adult, Aged, C-Reactive Protein, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Prospective Studies, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.